Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review

Progress in Polymer Science

Volumn 37, Issue 11, 2012, Pages 1457-1475

  Mukhopadhyay, Piyasi ^a   Mishra, Roshnara ^a   Rana, Dipak ^b   Kundu, Patit P ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Chitosan; Effective bio availability; Insulin; Nanoparticles; Oral delivery

Indexed keywords

ACIDIC ENVIRONMENT; APICAL SURFACES; BIO-AVAILABILITY; CHEMICAL BARRIERS; EFFECTIVE ABSORPTION; EPITHELIAL CELLS; GI TRACT; INSULIN DELIVERY; MODIFIED CHITOSAN; NEGATIVE CHARGE; NON-TOXICITY; ORAL ADMINISTRATION; ORAL DELIVERY; ORAL INSULIN DELIVERY; ORAL ROUTE; PARENTERAL ADMINISTRATION; PATIENT COMPLIANCE; PROTEOLYTIC ENZYME; SINGLE LAYER; SYNTHETIC SOURCES; TIGHT JUNCTIONS;

BIOCOMPATIBILITY; BIODEGRADATION; CELLS; INSULIN; NANOPARTICLES; NATURAL POLYMERS;

CHITOSAN;

EID: 84867262237     PISSN: 00796700     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progpolymsci.2012.04.004     Document Type: Review

References (121)

1. W. Rathmann, and G. Giani Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 2568 2569
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
3. V. Sabetsky, and J. Ekblom Insulin: a new era for an old hormone Pharmacological Research 61 2010 1 4
4. Khafagy el-S, M. Morishita, Y. Onuki, and K. Takayama Current challenges in non-invasive insulin delivery systems: a comparative review Advanced Drug Delivery Reviews 59 2007 1521 1546
5. F.P. Kennedy Recent developments in insulin delivery techniques. Current status and future potential Drugs 42 1991 213 227
6. M.M. Al-Tabakha, and A.I. Arida Recent challenges in insulin delivery systems: a review Indian Journal of Pharmaceutical Sciences 70 2008 278 286
7. V. Lassmann-Vague, and D. Raccah Alternatives routes of insulin delivery Diabetes and Metabolism 32 2006 513 522
8. D.R. Owens, B. Zinman, and G. Bolli Alternative routes of insulin delivery Diabetic Medicine 20 2003 886 898
9. K. Sonaje, K.J. Lin, S.P. Wey, C.K. Lin, T.H. Yeh, H.N. Nguyen, C.W. Hsu, T.C. Yen, J.H. Juang, and H.W. Sung Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection Biomaterials 31 2010 6849 6858
10. K. Sonaje, Y.J. Chen, H.L. Chen, S.P. Wey, J.H. Juang, H.N. Nguyen, C.W. Hsu, K.J. Lin, and H.W. Sung Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery Biomaterials 31 2010 3384 3394
11. G.P. Carino, and E. Mathiowitz Oral insulin delivery Advanced Drug Delivery Reviews 35 1999 249 257
12. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Préat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach Journal of Controlled Release 116 2006 1 27
13. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices Journal of Controlled Release 70 2001 1 20
14. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Advanced Drug Delivery Reviews 55 2003 329 347
15. W. Tiyaboonchai Chitosan nanoparticles: a promising system for drug delivery Naresuan University Journal 11 2003 51 66
16. G.M. Pauletti, S. Gangwar, G.T. Knipp, M.M. Nerurkar, F.W. Okumu, K. Tamura, T.J. Siahaan, and R.T. Borchardt Structural requirements for intestinal absorption of peptide drugs Journal of Controlled Release 41 1996 3 17
17. J.G. Still Development of oral insulin: progress and current status Diabetes/Metabolism Research and Reviews 18 2002 29 37
18. M. Morishita, T. Goto, K. Nakamura, A.M. Lowman, K. Takayama, and N.A. Peppas Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats Journal of Controlled Release 110 2006 587 594
19. T. Kimura, K. Sato, K. Sugimoto, R. Tao, T. Murakami, Y. Kurosaki, and T. Nakayama Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats Biological and Pharmaceutical Bulletin 19 1996 897 900
20. C. Damgé, H. Vranckx, P. Balschmidt, and P. Couvreur Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin Journal of Pharmaceutical Sciences 86 1997 1403 1409
21. M.K. Marschutz, P. Caliceti, and A. Bernkop-Schnurch Design and in vivo evaluation of an oral delivery system for insulin Pharmaceutical Research 17 2000 1468 1474
22. M.A. Radwant, and H.Y. Aboul-Enein The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats Journal of Microencapsulation 19 2002 225 235
23. I. Morishita, M. Morishita, K. Takayama, Y. Machida, and T. Nagai Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats International Journal of Pharmaceutics 78 1992 9 16
24. M. Mesiha, V. Plakogiannis, and V. Vejosoth Enhanced oral absorption of insulin from desolvated fatty acid-sodium glycocholate emulsions International Journal of Pharmaceutics 111 1994 213 216
25. H. Asada, T. Douen, M. Waki, S. Adachi, T. Fujita, A. Yamamoto, and S. Muranishi Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine Journal of Pharmaceutical Sciences 84 1995 682 687
26. M. George, and T.E. Abraham Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review Journal of Controlled Release 114 2006 1 14
27. R. Jayakumar, N. Nwe, S. Tokura, and H. Tamura Sulfated chitin and chitosan as novel biomaterials International Journal of Biological Macromolecules 40 2007 175 181
28. M. Rinaudo Chitin and chitosan: properties and applications Progress in Polymer Science 31 2006 603 632
29. M.P. Deacon, S. McGurk, and C.J. Roberts Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems Biochemical Journal 348 2000 557 563
30. V.R. Sinha, A.K. Singla, and S. Wadhawan Chitosan microspheres as a potential carrier for drugs International Journal of Pharmaceutics 274 2004 1 33
31. M.M. Issa, M. Köping-Höggård, and P. Artursson Chitosan and the mucosal delivery of biotechnology drugs Drug Discovery Today 2 2005 1 6
32. S. Hirano Chitin biotechnology applications Biotechnology Annual Review 2 1996 237 258
33. K. Nagpal, S.K. Singh, and D.N. Mishra Chitosan nanoparticles: a promising system in novel drug delivery Chemical and Pharmaceutical Bulletin 58 2010 1423 1430
34. T.W. Wong Chitosan and its use in design of insulin delivery system Recent Patents on Drug Delivery and Formulation 3 2009 8 25
35. M. Thanou, J.C. Verhoef, and H.E. Junginger Chitosan and its derivatives as intestinal absorption enhancers Advanced Drug Delivery Reviews 50 2001 91 101
36. E. Allémann, J. Leroux, and R. Gurny Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics Advanced Drug Delivery Reviews 34 1998 171 189
37. C.P. Reis Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity European Journal of Pharmaceutical Sciences 30 2007 392 397
38. K. Bowman, and K.W. Leong Chitosan nanoparticles for oral drug and gene delivery International Journal of Nanomedicine 1 2006 117 128
39. C. Pinto Reis, R.J. Neufeld, A.J. Ribeiro, and F. Veiga Nanoencapsulation: II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems Nanomedicine 2 2006 53 65
40. S.A. Agnihotri, and T.M. Aminabhavi Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine Journal of Microencapsulation 21 2004 709 718
41. Y. Pan, Y.J. Li, H.Y. Zhao, J.M. Zheng, H. Xu, G. Wei, J.S. Hao, and F.D. Cui Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo International Journal of Pharmaceutics 249 2002 139 147
42. S. Mao, U. Bakowsky, A. Jintapattanakit, and T. Kissel Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin Journal of Pharmaceutical Sciences 95 2006 1035 1048
43. Y.H. Lin, F.L. Mi, C.T. Chen, W.C. Chang, S.F. Peng, H.F. Liang, and H.W. Sung Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery Biomacromolecules 8 2007 146 152
44. A. Jintapattanakit, V.B. Junyaprasert, S. Mao, J. Sitterberg, U. Bakowsky, and T. Kissel Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles International Journal of Pharmaceutics 342 2007 240 249
45. B. Sarmento, A. Ribeiro, F. Veiga, and D. Ferreira Development and characterization of new insulin containing polysaccharide nanoparticles Colloids and Surfaces B 53 2006 193 202
46. B. Sarmento, A. Ribeiro, F. Veiga, P. Sampaio, R. Neufeld, and D. Ferreira Alginate/chitosan nanoparticles are effective for oral insulin delivery Pharmaceutical Research 24 2007 2198 2206
47. Y.H. Lin, K. Sonaje, K.M. Lin, J.H. Juang, F.L. Mi, H.W. Yang, and H.W. Sung Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs Journal of Controlled Release 132 2008 141 149
48. F.L. Mi, Y.Y. Wu, Y.H. Lin, K. Sonaje, Y.C. Ho, C.T. Chen, J.H. Juang, and H.W. Sung Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation Bioconjugate Chemistry 19 2008 1248 1255
49. A. Bayat, B. Larijani, S. Ahmadian, H.E. Junginger, and M. Rafiee-Tehrani Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives Nanomedicine 4 2008 115 120
50. A.M. Sadeghi, F.A. Dorkoosh, M.R. Avadi, M. Weinhold, A. Bayat, F. Delie, R. Gurny, B. Larijani, M. Rafiee-Tehrani, and H.E. Junginger Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells European Journal of Pharmaceutics and Biopharmaceutics 70 2008 270 278
51. M.R. Rekha, and C.P. Sharma pH sensitive succinyl chitosan microparticles: a preliminary investigation towards oral insulin delivery Trends in Biomaterials and Artificial Organs 21 2008 107 115
52. L. Yin, J. Ding, C. He, L. Cui, C. Tang, and C. Yin Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery Biomaterials 30 2009 5691 5700
53. F.A. Moghaddam, F. Atyabi, and R. Dinarvand Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles Nanomedicine 5 2009 208 215
54. M.R. Rekha, and C.P. Sharma Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption Journal of Controlled Release 135 2009 144 151
55. C.B. Woitiski, R.J. Neufeld, A.J. Ribeiro, and F. Veiga Colloidal carrier integrating biomaterials for oral insulin delivery: influence of component formulation on physicochemical and biological parameters Acta Biomaterialia 5 2009 2475 2484
56. G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, C. Boselli, and C. Caramella Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties AAPS PharmSciTech 11 2010 362 371
57. M.R. Avadi, A.M. Sadeghi, N. Mohammadpour, S. Abedin, F. Atyabi, R. Dinarvand, and M. Rafiee-Tehrani Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method Nanomedicine 6 2010 58 63
58. R. Shelma, W. Paul, and C.P. Sharma Development and characterization of self-aggregated nanoparticles from anacardoylated chitosan as a carrier for insulin Carbohydrate Polymers 80 2010 285 290
59. H. Tokumitsu, H. Ichikawa, and Y. Fukumori Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization Pharmaceutical Research 16 1999 1830 1835
60. S. Mao, O. Germershaus, D. Fischer, T. Linn, R. Schnepf, and T. Kissel Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells Pharmaceutical Research 22 2005 2058 2068
61. T.M. Kumar, W. Paul, C.P. Sharma, and M.A. Kuriachan Bioadhesive, pH responsive micromatrix for oral delivery of insulin Trends in Biomaterials and Artificial Organs 18 2005 198 202
62. T. Sakiyama, H. Takata, M. Kikuchi, and K. Nakanishi Polyelectrolyte complex gel with high pH-sensitivity prepared from dextran sulfate and chitosan Journal of Applied Polymer Science 73 1999 2227 2233
63. T. Sakiyama, H. Takata, T. Toga, and K. Nakanishi pH-sensitive shrinking of a dextran sulfate/chitosan complex gel and its promotion effect on the release of polymeric substances Journal of Applied Polymer Science 81 2001 667 674
64. T. Serizawa, M. Yamaguchi, A. Kishida, and M. Akashi Alternating gene expression in fibroblasts adhering to multilayers of chitosan and dextran sulfate Journal of Biomedical Materials Research 67 2003 1060 1063
65. Y. Chen, V.J. Mohanraj, and J.E. Parkin Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide Letters in Peptide Science 10 2004 621 629
66. N. Zhang, J. Li, W. Jiang, C. Ren, J. Li, J. Xin, and K. Li Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles International Journal of Pharmaceutics 393 2010 212 218
67. C. Damgé, M. Socha, N. Ubrich, and P. Maincent Poly(e-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes Journal of Pharmaceutical Sciences 99 2010 879 889
68. M. Jelvehgari, P. Zakeri-Milani, M.R. Siahi-Shadbad, B.D. Loveymi, A. Nokhodchi, Z. Azari, and H. Valizadeh Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights AAPS PharmSciTech 11 2010 1237 1242
69. U. Ubaidulla, R.K. Khar, F.J. Ahmad, Y. Sultana, and A.K. Panda Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin Journal of Pharmaceutical Sciences 96 2007 3010 3023
70. A. Bernkop-Schnürch The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins Journal of Controlled Release 52 1998 1 16
71. M.K. Marschütz, and A. Bernkop-Schnürch Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro Biomaterials 21 2000 1499 1507
72. A. Bernkop-Schnürch Chitosan and its derivatives: potential excipients for peroral peptide delivery systems International Journal of Pharmaceutics 194 2000 1 13
73. C.J. Thompson, L. Tetley, I.F. Uchegbu, and W.P. Cheng The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery International Journal of Pharmaceutics 376 2009 46 55
74. R. Narayani Oral delivery of insulin making needles needless Trends in Biomaterials and Artificial Organs 15 2001 12 16
75. V.M. Leitner, G.F. Walker, and A. Bernkop-Schnürch Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins European Journal of Pharmaceutics and Biopharmaceutics 56 2003 207 214
76. A. Bernkop-Schnürch, D. Guggi, and Y. Pinter Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system Journal of Controlled Release 94 2004 177 186
77. M.R. Avadi, A. Jalali, A.M. Sadeghi, K. Shamimi, K.H. Bayati, E. Nahid, A.R. Dehpour, and M. Rafiee-Tehrani Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies International Journal of Pharmaceutics 293 2005 83 89
78. P. Younessi, M.R. Avadi, K. Shamimi, A.M. Sadeghi, L. Moezi, E. Nahid, K. Bayati, A.R. Dehpour, and M. Rafiee-Tehrani Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery Acta Pharmaceutica 54 2004 339 345
79. M. Prabaharan, and J.F. Mano Chitosan-based particles as controlled drug delivery systems Drug Delivery 12 2005 41 57
80. S. Sajeesh, and C.P. Sharma Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery International Journal of Pharmaceutics 325 2006 147 154
81. S. Martins, B. Sarmento, E.B. Souto, and D.C. Ferreira Insulin-loaded alginate microspheres for oral delivery - effect of polysaccharide reinforcement on physicochemical properties and release profile Carbohydrate Polymers 69 2007 725 731
82. A.K. Singla, and M. Chawla Chitosan: some pharmaceutical and biological aspects- and update Journal of Pharmacy and Pharmacology 53 2001 1047 1067
83. R. Hejazi, and M. Amiji Chitosan-based gastrointestinal delivery systems Journal of Controlled Release 89 2003 151 165
84. S.M. van der Merwe, J.C. Verhoef, and J.H.M. Verheijden Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs European Journal of Pharmaceutics and Biopharmaceutics 58 2004 225 235
85. A.H. Krauland, D. Guggi, and A. Bernkop-Schnürch Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats Journal of Controlled Release 95 2004 547 555
86. S.J. Kim, S.R. Shin, D.I. Shin, I.Y. Kim, and S.I. Kim Synthesis and characteristics of semi-interpenetrating polymer network hydrogels based on chitosan and poly(hydroxy ethyl methacrylate) Journal of Applied Polymer Science 96 2005 86 92
87. A. Vyas, S. Saraf, and S. Saraf Cyclodextrin based novel drug delivery systems Journal of Inclusion Phenomena and Macrocyclic Chemistry 62 2008 23 42
88. D.C. Bibby, N.M. Davies, and I.G. Tucker Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems International Journal of Pharmaceutics 197 2000 1 11
89. Z. Shao, Y. Li, T. Chermak, and A.K. Mitra Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats Pharmaceutical Research 11 1994 1174 1179
90. A.M. Denadai, D. Ianzer, A.F. Alcântara, M.M. Santoro, C.F. Santos, I.S. Lula, A.C. de Camargo, A. Faljoni-Alario, R.A. dos Santos, and R.D. Sinisterra Novel pharmaceutical composition of bradykinin potentiating penta peptide with beta-cyclodextrin: physical-chemical characterization and anti-hypertensive evaluation International Journal of Pharmaceutics 336 2007 90 98
91. K. Sonaje, Y.H. Lin, J.H. Juang, S.P. Wey, C.T. Chen, and H.W. Sung In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery Biomaterials 30 2009 2329 2339
92. R. Shelma, and C.P. Sharma Acyl modified chitosan derivatives for oral delivery of insulin and curcumin Journal of Materials Science Materials in Medicine 21 2010 2133 2140
93. H. Liu, R. Tang, W.S. Pan, and Y. Zhang Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats Journal of Pharmacy and Pharmacology 55 2003 1523 1529
94. L. Zhang, H. Jiang, W. Zhu, L. Wu, L. Song, Q. Wu, and Y. Ren Improving the stability of insulin in solutions containing intestinal proteases in vitro International Journal of Molecular Sciences 9 2008 2376 2387
95. G. Perera, M. Greindl, T.F. Palmberger, and A. Bernkop-Schnürch Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: stability studies towards digestive enzymes of the intestine Drug Delivery 16 2009 254 260
96. S. Sajeesh, C. Vauthier, C. Gueutin, G. Ponchel, and C.P. Sharma Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery Acta Biomaterialia 6 2010 3072 3080
97. S. Yu, Y. Zhao, F. Wu, X. Zhang, W. Lü, H. Zhang, and Q. Zhang Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies International Journal of Pharmaceutics 281 2004 11 23
98. A.H. Krauland, V.M. Leitner, V. Grabovac, and A. Bernkop-Schnürch In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan Journal of Pharmaceutical Sciences 95 2006 2463 2472
99. P. Dondeti, H. Zia, and T.E. Needham In vivo evaluation of spray formulations of human insulin for nasal delivery International Journal of Pharmaceutics 122 1995 91 105
100. Z. Ma, T.M. Lim, and L.Y. Lim Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats International Journal of Pharmaceutics 293 2005 271 280
101. F. Cui, K. Shi, L. Zhang, A. Tao, and Y. Kawashima Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation Journal of Controlled Release 114 2006 242 250
102. C. Damgé, P. Maincent, and N. Ubrich Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats Journal of Controlled Release 117 2007 163 170
103. B. Sarmento, A. Ribeiro, F. Veiga, D. Ferreira, and R. Neufeld Oral bioavailability of insulin contained in polysaccharide nanoparticles Biomacromolecules 8 2007 3054 3060
104. F. Cui, F. Qian, Z. Zhao, L. Yin, C. Tang, and C. Yin Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles Biomacromolecules 10 2009 1253 1258
105. S.F. Aman, F. Hassan, B.S. Naqvi, and S.M. Hasan Studies of food drug interactions Pakistan Journal of Pharmaceutical Sciences 23 2010 313 320
106. J.G. Wagner Drug bioavailability studies Hospital Practice 12 1977 119 127
107. A. Melander Influence of food on the bioavailability of drugs Clinical Pharmacokinetics 3 1978 337 351
108. J. Koch-Weser Bioavailability of drugs (first of two parts) New England Journal of Medicine 291 1974 233 237
109. J. Koch-Weser Bioavailability of drugs (second of two parts) New England Journal of Medicine 291 1974 503 506
110. M. Horowitz, D. O'Donovan, K.L. Jones, C. Feinle, C.K. Rayner, and M. Samsom Gastric emptying in diabetes: clinical significance and treatment Diabetic Medicine 19 2002 177 194
111. G. Bernstein The diabetic stomach: management strategies for clinicians and patients Diabetes Spectrum 13 2000 11 15
112. M. Champion Gastroparesis Medicine North America 4 1991 2524 2531
113. M. Horowitz, M. Edelbroek, R. Fraser, A. Maddox, and J. Wishart Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance, and treatment Scandinavian Journal of Gastroenterology 26 1991 673 684
114. B.T. Kinsley, H.F. Gramm, and A.R. Rolla Diabetic gastroparesis: a review Journal of Diabetic Complications 564 1991 207 217
115. A. Keshavarzian, F.L. Iber, and J. Vaeth Gastric emptying in patients with insulin-requiring diabetes mellitus American Journal of Gastroenterology 82 1987 29 35
116. M. Feldman, and L.R. Schiller Disorders of gastrointestinal motility associated with diabetes mellitus Annals of Internal Medicine 98 1983 378 384
117. R.J. Fraser, M. Horowitz, A.F. Maddox, P.E. Harding, B.E. Chatterton, and J. Dent Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus Diabetologia 33 1990 675 680
118. I.L. MacGregor, R. Gueller, H.D. Watts, and J.H. Meyer The effect of hyperglycemia on gastric emptying in man Gastroenterology 70 1976 190 196
119. R.J. Fraser, M. Horowitz, and J. Dent Hyperglycemia stimulates pyloric motility in normal subjects Gut 32 1991 475 478
120. R. Soltero, and N. Ekwuribe The oral delivery of protein and peptide drugs - a report Innovations in Pharmaceutical Technology 1 2001 106 110
121. Y.H. Lin, C.T. Chen, H.F. Liang, A.R. Kulkarni, P.W. Lee, C.H. Chen, and H.W. Sung Novel nanoparticles for oral insulin delivery via the paracellular pathway Nanotechnology 18 2007 105102/1-11